|
|
|
|
LescolSun-Sentinel.com, The class of drugs includes such well-known drugs as Lipitor (atorvastatin), Pravachol (pravastatin), Zocor (simvastatin), Lescol (fluvastatin) and Mevacor ... Medicare, Taxpayers Could Save $8.2 Billion a Year if Seniors ... Jan 12, 2006 SeniorJournal.com, October 2005. Several brand-name statins experienced declining prescriptions, including Lescol and Pravachol. Lipitor prescriptions ... Two Studies Show Statins Don't Cut Cancer Risk Jan 4, 2006 Los Angeles Times, Statins are the most commonly prescribed medications in the United States and include Lipitor, Zocor, Mevacor, Crestor, Pravachol and Lescol. ... Statins ineffective on cancer, studies say Jan 8, 2006 Indianapolis Star, ...the most commonly prescribed medications in the US, and as a result possess unrivaled name recognition: Lipitor, Zocor, Mevacor, Crestor, Pravachol and Lescol. ... Study: Statins don't fight cancer Jan 6, 2006 myDNA.com, Statins, which include the drugs Lipitor, Zocor, Mevaco, Crestor, Pravachol and Lescol, are used to lower cholesterol and prevent heart disease. ... Statins thought to prevent cancer, in fact do not. Jan 4, 2006 Food Consumer, For years, Satins, that include drugs such as Zacor, Crestor, Lipitor, Mevacor, Pravachol and Lescol, were believed to reduce cancer because they reduced ... Studies: Statins Don't Cut Risk of Colon, Other Cancers Jan 9, 2006 ACS News Center, The specific statins studied included atorvastatin (Lipitor, Caduet), cerivastatin (Baycol), fluvastatin (Lescol), lovastatin (Advicor, Altoprev, Mevacor ... Novartis Abandons Development of Cholesterol Drug (Update1) Dec 15, 2005 Bloomberg The company already took a charge of $66 million in the third quarter for the drug. Novartis sells another cholesterol treatment called Lescol. ... Novartis abandons new cholesterol drug Dec 16, 2005 MSN Money ...in the United States. Among the most high profile statins available are Pfizer's Lipitor and Novartis' own Lescol. NKS104 was in ... Novartis: cardio refocus should reward Dec 20, 2005 Pharmaceutical Business Review With the company’s other statin, Lescol (fluvastatin), commanding only 4% of the total statin market, many saw Novartis' acquisition as an attempt to boost ... Statins do not affect cancer risk, researchers say Jan 3, 2006 Reuters ...drugs in the world, include Pfizer Inc.'s Lipitor, Merck & Co Inc.'s Zocor, Bristol-Myers Squibb's Pravachol, Merck's Mevacor and Novartis AG's Lescol. ... Statins do not affect cancer risk, researchers say Jan 3, 2006 Reuters BMY.N: Quote, Profile, Research) Pravachol, Merck's Mevacor and Novartis AG's (NOVN.VX: Quote, Profile, Research)(NVS.N: Quote, Profile, Research) Lescol. ... Statins don't appear to lower cancer risk Jan 3, 2006 Newsday, ...commonly prescribed medications in the United States and as a result possess unrivaled name recognition: Lipitor, Zocor, Mevacor, Crestor, Pravachol and Lescol ... No Link Found Between Cholesterol Lowering Drugs and Colorectal ... Jan 3, 2006 BlackHillsPortal.com, ...almost 50 percent. Some of the more commonly prescribed statins are Lipitor, Zocor, Pravachol, Lescol, Mevacor and Crestor. For the ... Meta-Analysis Rules Out Statin Cancer Prevention Jan 3, 2006 MedPage Today, The studies examined six statins - Mevacor (lovastatin), Lipitor (atorvastatin), Vytorin (simvastatin), Baycol (cerivastatin), Lescol (fluvastatin), and ... Novartis drops cholesterol drug Dec 16, 2005 Business Standard, ...the United States. Among the most high profile statins available are Pfizer’s Lipitor and Novartis’ own Lescol. NKS104 was in ... Cholesterol Pills and Grapefruit Don’t Mix Dec 27, 2005 PakTribune.com, The grapefruit hazard is not significant for other statins, such as Novartis AG’s Lescol, Bristol-Myers Squibb Co’s Pravachol and AstraZeneca Plc’s ... Expanding Need for Lipid Modulation Drives Market to New Heights Dec 19, 2005 PR Newswire (press release), ...patent protection in 2006. Lipitor, the leader, and Lescol will also lose patent protection by the end of 2011. The statin class ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |